 | • レポートコード：MRC2-11QY04505 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は咽頭後膿瘍のグローバル市場について調査・分析したレポートです。種類別（抗生物質、鎮痛剤、外科的ドレナージ、その他）市場規模、用途別（病院・診療所、研究・学術、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別咽頭後膿瘍の競争状況、市場シェア ・世界の咽頭後膿瘍市場：種類別市場規模 2015年-2020年（抗生物質、鎮痛剤、外科的ドレナージ、その他） ・世界の咽頭後膿瘍市場：種類別市場規模予測 2021年-2026年（抗生物質、鎮痛剤、外科的ドレナージ、その他） ・世界の咽頭後膿瘍市場：用途別市場規模 2015年-2020年（病院・診療所、研究・学術、その他） ・世界の咽頭後膿瘍市場：用途別市場規模予測 2021年-2026年（病院・診療所、研究・学術、その他） ・北米の咽頭後膿瘍市場分析：米国、カナダ ・ヨーロッパの咽頭後膿瘍市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの咽頭後膿瘍市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の咽頭後膿瘍市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの咽頭後膿瘍市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Merck KGaA、Johnson & Johnson、AstraZeneca plc.、Sanofi S.A.、Pfizer、Mylan N.V.、Novartis AG、Teva pharmaceutical company、GlaxoSmithKline plc. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
A retropharyngeal abscess is a serious infection, usually starts in the lymph nodes, characterised by collection of pus at the back of the throat. Retropharyngeal abscess typically occurs in children under the age of eight, sometimes it can also affect adults. The symptoms of retropharyngeal abscess include difficulty or noisy breathing, difficulty and pain while swallowing, drooling, severe cough, severe throat pain, neck stiffness or swelling, muscle spasms in the neck among others. Retropharyngeal abscess is generally preceded by upper respiratory infections mostly a middle ear or sinus infection.
A significant market share of the global retropharyngeal abscess market is held by the Americas, owing to high expenditure on the health care especially in major countries of the region like the U.S. and Canada. Additionally, the number of cardiac procedures in the U.S and Canada is increasing due to greater healthcare penetration, which drives the retropharyngeal abscess market. The high concentration of the major hospitals in the developed countries of this region coupled with good reimbursement rates is adding fuel to the market growth. Moreover, the large share of infective procedures treatment in the returns of hospitals favors the market. The large number of pharmaceutical companies in the U.S. is also a cause for the faster development of retropharyngeal abscess market in the US. The development of broad spectrum antibiotics in developed regions such as the U.S. and Europe is a strong driver of the market.
Market Analysis and Insights: Global Retropharyngeal Abscess Market
The global Retropharyngeal Abscess market size is projected to reach US$ 4602 million by 2026, from US$ 4478.4 million in 2020, at a CAGR of 2.6%% during 2021-2026.
Global Retropharyngeal Abscess Scope and Market Size
Retropharyngeal Abscess market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Retropharyngeal Abscess market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Merck KGaA
Johnson & Johnson
AstraZeneca plc.
Sanofi S.A.
Pfizer
Mylan N.V.
Novartis AG
Teva pharmaceutical company
GlaxoSmithKline plc.
Market segment by Type, the product can be split into
Antibiotics
Pain Killers
Surgical Drainage
Others
Market segment by Application, split into
Hospitals and Clinics
Research and Academics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Retropharyngeal Abscess Revenue
1.4 Market by Type
1.4.1 Global Retropharyngeal Abscess Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Antibiotics
1.4.3 Pain Killers
1.4.4 Surgical Drainage
1.4.5 Others
1.5 Market by Application
1.5.1 Global Retropharyngeal Abscess Market Share by Application: 2020 VS 2026
1.5.2 Hospitals and Clinics
1.5.3 Research and Academics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Retropharyngeal Abscess Market Perspective (2015-2026)
2.2 Global Retropharyngeal Abscess Growth Trends by Regions
2.2.1 Retropharyngeal Abscess Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Retropharyngeal Abscess Historic Market Share by Regions (2015-2020)
2.2.3 Retropharyngeal Abscess Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Retropharyngeal Abscess Market Growth Strategy
2.3.6 Primary Interviews with Key Retropharyngeal Abscess Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Retropharyngeal Abscess Players by Market Size
3.1.1 Global Top Retropharyngeal Abscess Players by Revenue (2015-2020)
3.1.2 Global Retropharyngeal Abscess Revenue Market Share by Players (2015-2020)
3.1.3 Global Retropharyngeal Abscess Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Retropharyngeal Abscess Market Concentration Ratio
3.2.1 Global Retropharyngeal Abscess Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Retropharyngeal Abscess Revenue in 2019
3.3 Retropharyngeal Abscess Key Players Head office and Area Served
3.4 Key Players Retropharyngeal Abscess Product Solution and Service
3.5 Date of Enter into Retropharyngeal Abscess Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Retropharyngeal Abscess Historic Market Size by Type (2015-2020)
4.2 Global Retropharyngeal Abscess Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Retropharyngeal Abscess Market Size by Application (2015-2020)
5.2 Global Retropharyngeal Abscess Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Retropharyngeal Abscess Market Size (2015-2020)
6.2 Retropharyngeal Abscess Key Players in North America (2019-2020)
6.3 North America Retropharyngeal Abscess Market Size by Type (2015-2020)
6.4 North America Retropharyngeal Abscess Market Size by Application (2015-2020)
7 Europe
7.1 Europe Retropharyngeal Abscess Market Size (2015-2020)
7.2 Retropharyngeal Abscess Key Players in Europe (2019-2020)
7.3 Europe Retropharyngeal Abscess Market Size by Type (2015-2020)
7.4 Europe Retropharyngeal Abscess Market Size by Application (2015-2020)
8 China
8.1 China Retropharyngeal Abscess Market Size (2015-2020)
8.2 Retropharyngeal Abscess Key Players in China (2019-2020)
8.3 China Retropharyngeal Abscess Market Size by Type (2015-2020)
8.4 China Retropharyngeal Abscess Market Size by Application (2015-2020)
9 Japan
9.1 Japan Retropharyngeal Abscess Market Size (2015-2020)
9.2 Retropharyngeal Abscess Key Players in Japan (2019-2020)
9.3 Japan Retropharyngeal Abscess Market Size by Type (2015-2020)
9.4 Japan Retropharyngeal Abscess Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Retropharyngeal Abscess Market Size (2015-2020)
10.2 Retropharyngeal Abscess Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Retropharyngeal Abscess Market Size by Type (2015-2020)
10.4 Southeast Asia Retropharyngeal Abscess Market Size by Application (2015-2020)
11 India
11.1 India Retropharyngeal Abscess Market Size (2015-2020)
11.2 Retropharyngeal Abscess Key Players in India (2019-2020)
11.3 India Retropharyngeal Abscess Market Size by Type (2015-2020)
11.4 India Retropharyngeal Abscess Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Retropharyngeal Abscess Market Size (2015-2020)
12.2 Retropharyngeal Abscess Key Players in Central & South America (2019-2020)
12.3 Central & South America Retropharyngeal Abscess Market Size by Type (2015-2020)
12.4 Central & South America Retropharyngeal Abscess Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Merck KGaA
13.1.1 Merck KGaA Company Details
13.1.2 Merck KGaA Business Overview
13.1.3 Merck KGaA Retropharyngeal Abscess Introduction
13.1.4 Merck KGaA Revenue in Retropharyngeal Abscess Business (2015-2020))
13.1.5 Merck KGaA Recent Development
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Details
13.2.2 Johnson & Johnson Business Overview
13.2.3 Johnson & Johnson Retropharyngeal Abscess Introduction
13.2.4 Johnson & Johnson Revenue in Retropharyngeal Abscess Business (2015-2020)
13.2.5 Johnson & Johnson Recent Development
13.3 AstraZeneca plc.
13.3.1 AstraZeneca plc. Company Details
13.3.2 AstraZeneca plc. Business Overview
13.3.3 AstraZeneca plc. Retropharyngeal Abscess Introduction
13.3.4 AstraZeneca plc. Revenue in Retropharyngeal Abscess Business (2015-2020)
13.3.5 AstraZeneca plc. Recent Development
13.4 Sanofi S.A.
13.4.1 Sanofi S.A. Company Details
13.4.2 Sanofi S.A. Business Overview
13.4.3 Sanofi S.A. Retropharyngeal Abscess Introduction
13.4.4 Sanofi S.A. Revenue in Retropharyngeal Abscess Business (2015-2020)
13.4.5 Sanofi S.A. Recent Development
13.5 Pfizer
13.5.1 Pfizer Company Details
13.5.2 Pfizer Business Overview
13.5.3 Pfizer Retropharyngeal Abscess Introduction
13.5.4 Pfizer Revenue in Retropharyngeal Abscess Business (2015-2020)
13.5.5 Pfizer Recent Development
13.6 Mylan N.V.
13.6.1 Mylan N.V. Company Details
13.6.2 Mylan N.V. Business Overview
13.6.3 Mylan N.V. Retropharyngeal Abscess Introduction
13.6.4 Mylan N.V. Revenue in Retropharyngeal Abscess Business (2015-2020)
13.6.5 Mylan N.V. Recent Development
13.7 Novartis AG
13.7.1 Novartis AG Company Details
13.7.2 Novartis AG Business Overview
13.7.3 Novartis AG Retropharyngeal Abscess Introduction
13.7.4 Novartis AG Revenue in Retropharyngeal Abscess Business (2015-2020)
13.7.5 Novartis AG Recent Development
13.8 Teva pharmaceutical company
13.8.1 Teva pharmaceutical company Company Details
13.8.2 Teva pharmaceutical company Business Overview
13.8.3 Teva pharmaceutical company Retropharyngeal Abscess Introduction
13.8.4 Teva pharmaceutical company Revenue in Retropharyngeal Abscess Business (2015-2020)
13.8.5 Teva pharmaceutical company Recent Development
13.9 GlaxoSmithKline plc.
13.9.1 GlaxoSmithKline plc. Company Details
13.9.2 GlaxoSmithKline plc. Business Overview
13.9.3 GlaxoSmithKline plc. Retropharyngeal Abscess Introduction
13.9.4 GlaxoSmithKline plc. Revenue in Retropharyngeal Abscess Business (2015-2020)
13.9.5 GlaxoSmithKline plc. Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Retropharyngeal Abscess Key Market Segments
Table 2. Key Players Covered: Ranking by Retropharyngeal Abscess Revenue
Table 3. Ranking of Global Top Retropharyngeal Abscess Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Retropharyngeal Abscess Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Antibiotics
Table 6. Key Players of Pain Killers
Table 7. Key Players of Surgical Drainage
Table 8. Key Players of Others
Table 9. Global Retropharyngeal Abscess Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Retropharyngeal Abscess Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Retropharyngeal Abscess Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Retropharyngeal Abscess Market Share by Regions (2015-2020)
Table 13. Global Retropharyngeal Abscess Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Retropharyngeal Abscess Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Retropharyngeal Abscess Market Growth Strategy
Table 19. Main Points Interviewed from Key Retropharyngeal Abscess Players
Table 20. Global Retropharyngeal Abscess Revenue by Players (2015-2020) (Million US$)
Table 21. Global Retropharyngeal Abscess Market Share by Players (2015-2020)
Table 22. Global Top Retropharyngeal Abscess Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retropharyngeal Abscess as of 2019)
Table 23. Global Retropharyngeal Abscess by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Retropharyngeal Abscess Product Solution and Service
Table 26. Date of Enter into Retropharyngeal Abscess Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Retropharyngeal Abscess Market Size by Type (2015-2020) (Million US$)
Table 29. Global Retropharyngeal Abscess Market Size Share by Type (2015-2020)
Table 30. Global Retropharyngeal Abscess Revenue Market Share by Type (2021-2026)
Table 31. Global Retropharyngeal Abscess Market Size Share by Application (2015-2020)
Table 32. Global Retropharyngeal Abscess Market Size by Application (2015-2020) (Million US$)
Table 33. Global Retropharyngeal Abscess Market Size Share by Application (2021-2026)
Table 34. North America Key Players Retropharyngeal Abscess Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Retropharyngeal Abscess Market Share (2019-2020)
Table 36. North America Retropharyngeal Abscess Market Size by Type (2015-2020) (Million US$)
Table 37. North America Retropharyngeal Abscess Market Share by Type (2015-2020)
Table 38. North America Retropharyngeal Abscess Market Size by Application (2015-2020) (Million US$)
Table 39. North America Retropharyngeal Abscess Market Share by Application (2015-2020)
Table 40. Europe Key Players Retropharyngeal Abscess Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Retropharyngeal Abscess Market Share (2019-2020)
Table 42. Europe Retropharyngeal Abscess Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Retropharyngeal Abscess Market Share by Type (2015-2020)
Table 44. Europe Retropharyngeal Abscess Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Retropharyngeal Abscess Market Share by Application (2015-2020)
Table 46. China Key Players Retropharyngeal Abscess Revenue (2019-2020) (Million US$)
Table 47. China Key Players Retropharyngeal Abscess Market Share (2019-2020)
Table 48. China Retropharyngeal Abscess Market Size by Type (2015-2020) (Million US$)
Table 49. China Retropharyngeal Abscess Market Share by Type (2015-2020)
Table 50. China Retropharyngeal Abscess Market Size by Application (2015-2020) (Million US$)
Table 51. China Retropharyngeal Abscess Market Share by Application (2015-2020)
Table 52. Japan Key Players Retropharyngeal Abscess Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Retropharyngeal Abscess Market Share (2019-2020)
Table 54. Japan Retropharyngeal Abscess Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Retropharyngeal Abscess Market Share by Type (2015-2020)
Table 56. Japan Retropharyngeal Abscess Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Retropharyngeal Abscess Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Retropharyngeal Abscess Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Retropharyngeal Abscess Market Share (2019-2020)
Table 60. Southeast Asia Retropharyngeal Abscess Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Retropharyngeal Abscess Market Share by Type (2015-2020)
Table 62. Southeast Asia Retropharyngeal Abscess Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Retropharyngeal Abscess Market Share by Application (2015-2020)
Table 64. India Key Players Retropharyngeal Abscess Revenue (2019-2020) (Million US$)
Table 65. India Key Players Retropharyngeal Abscess Market Share (2019-2020)
Table 66. India Retropharyngeal Abscess Market Size by Type (2015-2020) (Million US$)
Table 67. India Retropharyngeal Abscess Market Share by Type (2015-2020)
Table 68. India Retropharyngeal Abscess Market Size by Application (2015-2020) (Million US$)
Table 69. India Retropharyngeal Abscess Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Retropharyngeal Abscess Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Retropharyngeal Abscess Market Share (2019-2020)
Table 72. Central & South America Retropharyngeal Abscess Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Retropharyngeal Abscess Market Share by Type (2015-2020)
Table 74. Central & South America Retropharyngeal Abscess Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Retropharyngeal Abscess Market Share by Application (2015-2020)
Table 76. Merck KGaA Company Details
Table 77. Merck KGaA Business Overview
Table 78. Merck KGaA Product
Table 79. Merck KGaA Revenue in Retropharyngeal Abscess Business (2015-2020) (Million US$)
Table 80. Merck KGaA Recent Development
Table 81. Johnson & Johnson Company Details
Table 82. Johnson & Johnson Business Overview
Table 83. Johnson & Johnson Product
Table 84. Johnson & Johnson Revenue in Retropharyngeal Abscess Business (2015-2020) (Million US$)
Table 85. Johnson & Johnson Recent Development
Table 86. AstraZeneca plc. Company Details
Table 87. AstraZeneca plc. Business Overview
Table 88. AstraZeneca plc. Product
Table 89. AstraZeneca plc. Revenue in Retropharyngeal Abscess Business (2015-2020) (Million US$)
Table 90. AstraZeneca plc. Recent Development
Table 91. Sanofi S.A. Company Details
Table 92. Sanofi S.A. Business Overview
Table 93. Sanofi S.A. Product
Table 94. Sanofi S.A. Revenue in Retropharyngeal Abscess Business (2015-2020) (Million US$)
Table 95. Sanofi S.A. Recent Development
Table 96. Pfizer Company Details
Table 97. Pfizer Business Overview
Table 98. Pfizer Product
Table 99. Pfizer Revenue in Retropharyngeal Abscess Business (2015-2020) (Million US$)
Table 100. Pfizer Recent Development
Table 101. Mylan N.V. Company Details
Table 102. Mylan N.V. Business Overview
Table 103. Mylan N.V. Product
Table 104. Mylan N.V. Revenue in Retropharyngeal Abscess Business (2015-2020) (Million US$)
Table 105. Mylan N.V. Recent Development
Table 106. Novartis AG Company Details
Table 107. Novartis AG Business Overview
Table 108. Novartis AG Product
Table 109. Novartis AG Revenue in Retropharyngeal Abscess Business (2015-2020) (Million US$)
Table 110. Novartis AG Recent Development
Table 111. Teva pharmaceutical company Business Overview
Table 112. Teva pharmaceutical company Product
Table 113. Teva pharmaceutical company Company Details
Table 114. Teva pharmaceutical company Revenue in Retropharyngeal Abscess Business (2015-2020) (Million US$)
Table 115. Teva pharmaceutical company Recent Development
Table 116. GlaxoSmithKline plc. Company Details
Table 117. GlaxoSmithKline plc. Business Overview
Table 118. GlaxoSmithKline plc. Product
Table 119. GlaxoSmithKline plc. Revenue in Retropharyngeal Abscess Business (2015-2020) (Million US$)
Table 120. GlaxoSmithKline plc. Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retropharyngeal Abscess Market Share by Type: 2020 VS 2026
Figure 2. Antibiotics Features
Figure 3. Pain Killers Features
Figure 4. Surgical Drainage Features
Figure 5. Others Features
Figure 6. Global Retropharyngeal Abscess Market Share by Application: 2020 VS 2026
Figure 7. Hospitals and Clinics Case Studies
Figure 8. Research and Academics Case Studies
Figure 9. Others Case Studies
Figure 10. Retropharyngeal Abscess Report Years Considered
Figure 11. Global Retropharyngeal Abscess Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Retropharyngeal Abscess Market Share by Regions: 2020 VS 2026
Figure 13. Global Retropharyngeal Abscess Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Retropharyngeal Abscess Market Share by Players in 2019
Figure 16. Global Top Retropharyngeal Abscess Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retropharyngeal Abscess as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Retropharyngeal Abscess Revenue in 2019
Figure 18. North America Retropharyngeal Abscess Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Retropharyngeal Abscess Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Retropharyngeal Abscess Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Retropharyngeal Abscess Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Retropharyngeal Abscess Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Retropharyngeal Abscess Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Retropharyngeal Abscess Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
歯科用感染症治療の世界市場（～2026年） Dental infection or tooth abscess is the infection of teeth, gums and associated tissue caused by a bacterial infection. The abscess can occur at different regions such as periapical abscess occurring at the tip of the root, and a periodontal abscess occurring in the gums next to a tooth root. Tooth…- 慢性腰痛治療の世界市場（～2026年） Low back pain can be standardized into two categories, acute and chronic. Pain for less than three months can be classified as acute, while continued pain for more than three months is classified as chronic. Market Analysis and Insights: Global Chronic Low Back Pain Treatment Market The global Chron…
- 獣医疼痛管理の世界市場（～2026年） Outpatient veterinary pain management centers and practitioners are actively taking a role in treating many “problematic” issues which plague veterinary patients. North America dominated the veterinary pain management market, followed by Europe. In North America, the US is expected to hold the large…
- 内臓痛の世界市場（～2026年） Visceral pain is pain that results from the activation of nociceptors of the thoracic, pelvic, or abdominal viscera (organs). Visceral structures are highly sensitive to distension (stretch), ischemia and inflammation, but relatively insensitive to other stimuli that normally evoke pain such as cutt…
- 術後疼痛管理の世界市場（～2026年） Postoperative pain management aims to minimise patient discomfort, facilitate early mobilization and functional recovery, and prevent acute pain developing into chronic pain. Mental health can affect a patient’s recovery and psychological vulnerability is predictive of severe postoperative pain. Edu…